论文部分内容阅读
本文对晚期肺鳞癌病人中联合应用环磷酰胺、长春新硷、甲基CCNU、博莱霉素治疗(COMB)与单用环磷酰胺(CTX)治疗的效果进行了比较。经病理证实、转移范围超过同侧斜角肌淋巴结或有其他器官受累的肺鳞癌患者,并且未曾接受化疗者为选择对象,包括接受过外科治疗或放射治疗者。将病人随机分为COMB和CTX两组。COMB联合治疗的给药方法为:第一天甲基CCNU 100毫克/
This article compares the efficacy of combined cyclophosphamide, vinorelbine, methyl-CCNU, bleomycin treatment (COMB) and cyclophosphamide alone (CTX) in patients with advanced lung squamous cell carcinoma. Patients with lung squamous cell carcinoma whose pathological findings were confirmed to be greater than those of the same scaled lymph node or other organs and who had not received chemotherapy were selected, including those who had undergone surgery or radiation therapy. The patients were randomly divided into COMB and CTX groups. COMB combination therapy was administered on the first day of methyl CCNU 100 mg/